Futura Medical plc (AIM:FUM)
London · Delayed Price · Currency is GBP · Price in GBX 9.70
-0.16 (-1.62%)
Aug 15, 2025, 4:35 PM GMT+1
Futura Medical Company Description
Futura Medical plc research, develops, and sells pharmaceutical and healthcare products for sexual health.
Its lead product is Eroxon, a topical gel for the treatment of erectile dysfunction. It also develops WSD4000 for the treatment of sexual dysfunction in women.
The company operates in the United Kingdom, the European Union, the United States, and internationally.
Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.
Futura Medical plc
| Country | United Kingdom |
| Founded | 2001 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 14 |
| CEO | James Barder |
Contact Details
Address: Surrey Technology Centre Guildford, GU2 7YG United Kingdom | |
| Phone | 44 14 8368 5670 |
| Website | futuramedical.com |
Stock Details
| Ticker Symbol | FUM |
| Exchange | London Stock Exchange AIM |
| Fiscal Year | January - December |
| Reporting Currency | GBP |
| ISIN Number | GB0033278473 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| James Barder | Chief Executive Officer |
| Angela Hildreth | Chief Financial Officer |
| Angela Hildreth | Chief Operating Officer |